The Food and Drug Administration today released for comment draft guidance clarifying what types of clinical and patient decision support software would no longer be regulated by the agency as a medical device under the 21st Century Cures Act. FDA Commissioner Scott Gottlieb, M.D., said the guidance generally excludes from regulation software that allows a health care provider or patient to independently review the basis for its treatment recommendations. In addition, FDA released draft guidance clarifying that certain digital health technologies, such as mobile apps intended solely to maintain or encourage a healthy lifestyle, generally fall outside the scope of FDA regulation under the Act, and final guidance adopting international principles for harmonizing the regulation of software with a medical purpose.

Related News Articles

Headline
The AHA Oct. 6 released a Cybersecurity Advisory urging immediate action against a critical Oracle E-Business Suite vulnerability that is remotely exploitable…
Headline
The AHA has launched an enhanced Cybersecurity and Risk webpage designed to help health care organizations strengthen their defenses against emerging cyber and…
Headline
A Health-ISAC (Information Sharing and Analysis Center) bulletin released Oct. 1 warns of a recently released LockBit 5.0 ransomware variant that poses a…
Headline
The Department of Health and Human Services announced Sept. 30 that it is doubling its funding for childhood cancer research from $50 million to $100 million…
Headline
Fernando Martinez, Ph.D., chief digital officer at the Texas Hospital Association, shares how Texas and the THA are building regional resilience through cyber…
Headline
The federal government shut down Oct. 1 following a failed Senate vote on the House-passed continuing resolution to fund the government by midnight Sept. 30.…